Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

More articles from ENDOCRINE AND REPRODUCTIVE

  • You have access
    Hypoglycemic Effect of Insulin-Transferrin Conjugate in Streptozotocin-Induced Diabetic Rats
    Cindy Q. Xia, Jeff Wang and Wei-Chiang Shen
    Journal of Pharmacology and Experimental Therapeutics November 2000, 295 (2) 594-600;
  • You have access
    Beneficial Insulin-Sensitizing and Vascular Effects of S15261 in the Insulin-Resistant JCR:LA-cp Rat
    James C. Russell, Denis Ravel, Jean-Paul Pégorier, Pascal Delrat, Roeline Jochemsen, Sheila F. O'Brien, Sandra E. Kelly, Sandra T. Davidge and David N. Brindley
    Journal of Pharmacology and Experimental Therapeutics November 2000, 295 (2) 753-760;
  • You have access
    Tuberoinfundibular Peptide (7-39) [TIP(7-39)], a Novel, Selective, High-Affinity Antagonist for the Parathyroid Hormone-1 Receptor with No Detectable Agonist Activity
    Sam R. J. Hoare and Ted B. Usdin
    Journal of Pharmacology and Experimental Therapeutics November 2000, 295 (2) 761-770;
  • You have access
    Estrogen Inhibition of Cystic Fibrosis Transmembrane Conductance Regulator-Mediated Chloride Secretion
    Ashvani K. Singh, Bruce D. Schultz, John A. Katzenellenbogen, Elmer M. Price, Robert J. Bridges and Neil A. Bradbury
    Journal of Pharmacology and Experimental Therapeutics October 2000, 295 (1) 195-204;
  • You have access
    The Effects of Cocaine on Basal and Human Chorionic Gonadotropin-Stimulated Ovarian Steroid Hormones in Female Rhesus Monkeys
    Nancy K. Mello, Jack H. Mendelson, Maureen Kelly and Carrie A. Bowen
    Journal of Pharmacology and Experimental Therapeutics September 2000, 294 (3) 1137-1145;
  • You have access
    Troglitazone Directly Inhibits CO2 Production from Glucose and Palmitate in Isolated Rat Skeletal Muscle
    Clemens Fürnsinn, Barbara Brunmair, Susanne Neschen, Michael Roden and Werner Waldhäusl
    Journal of Pharmacology and Experimental Therapeutics May 2000, 293 (2) 487-493;
  • You have access
    Long-Term Effects of the EndothelinA Receptor Antagonist LU 135252 and the Angiotensin-Converting Enzyme Inhibitor Trandolapril on Diabetic Angiopathy and Nephropathy in a Chronic Type I Diabetes Mellitus Rat Model
    Stefan Dhein, Stefan Hochreuther, Christian aus dem Spring, Klaus Bollig, Christine Hufnagel and Manfred Raschack
    Journal of Pharmacology and Experimental Therapeutics May 2000, 293 (2) 351-359;
  • You have access
    Pancreatic β-Cell K ATP Channel Activity and Membrane-Binding Studies with Nateglinide: A Comparison with Sulfonylureas and Repaglinide
    Shiling Hu, Shuya Wang, Barbara Fanelli, Philip A. Bell, Beth E. Dunning, Sabine Geisse, Rita Schmitz and Brian R. Boettcher
    Journal of Pharmacology and Experimental Therapeutics May 2000, 293 (2) 444-452;
  • You have access
    A Mibefradil Metabolite Is a Potent Intracellular Blocker of L-Type Ca2+ Currents in Pancreatic β-Cells
    Songwei Wu, Min Zhang, Pamela A. Vest, Arin Bhattacharjee, Li Liu and Ming Li
    Journal of Pharmacology and Experimental Therapeutics March 2000, 292 (3) 939-943;
  • You have access
    Functional and Molecular Properties of the Human Recombinant Y4 Receptor: Resistance to Agonist-Promoted Desensitization
    Thierry Voisin, Mathieu Goumain, Anne-Marie Lorinet, Jean-José Maoret and Marc Laburthe
    Journal of Pharmacology and Experimental Therapeutics February 2000, 292 (2) 638-646;

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics